BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 26437604)

  • 1. Ironing out Ferroportin.
    Drakesmith H; Nemeth E; Ganz T
    Cell Metab; 2015 Nov; 22(5):777-87. PubMed ID: 26437604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis.
    Nemeth E; Ganz T
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepcidin and iron homeostasis.
    Ganz T; Nemeth E
    Biochim Biophys Acta; 2012 Sep; 1823(9):1434-43. PubMed ID: 22306005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic iron homeostasis.
    Ganz T
    Physiol Rev; 2013 Oct; 93(4):1721-41. PubMed ID: 24137020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms.
    Billesbølle CB; Azumaya CM; Kretsch RC; Powers AS; Gonen S; Schneider S; Arvedson T; Dror RO; Cheng Y; Manglik A
    Nature; 2020 Oct; 586(7831):807-811. PubMed ID: 32814342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron Balance and the Role of Hepcidin in Chronic Kidney Disease.
    Ganz T; Nemeth E
    Semin Nephrol; 2016 Mar; 36(2):87-93. PubMed ID: 27236128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An essential cell-autonomous role for hepcidin in cardiac iron homeostasis.
    Lakhal-Littleton S; Wolna M; Chung YJ; Christian HC; Heather LC; Brescia M; Ball V; Diaz R; Santos A; Biggs D; Clarke K; Davies B; Robbins PA
    Elife; 2016 Nov; 5():. PubMed ID: 27897970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron Availability in Tissue Microenvironment: The Key Role of Ferroportin.
    Gammella E; Correnti M; Cairo G; Recalcati S
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin and iron regulation, 10 years later.
    Ganz T
    Blood; 2011 Apr; 117(17):4425-33. PubMed ID: 21346250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic iron homeostasis and erythropoiesis.
    Papanikolaou G; Pantopoulos K
    IUBMB Life; 2017 Jun; 69(6):399-413. PubMed ID: 28387022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis of iron overload disorders and iron-linked anemias.
    Kaplan J; Ward DM; De Domenico I
    Int J Hematol; 2011 Jan; 93(1):14-20. PubMed ID: 21210258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophages and systemic iron homeostasis.
    Ganz T
    J Innate Immun; 2012; 4(5-6):446-53. PubMed ID: 22441209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepcidin targets ferroportin for degradation in hepatocytes.
    Ramey G; Deschemin JC; Durel B; Canonne-Hergaux F; Nicolas G; Vaulont S
    Haematologica; 2010 Mar; 95(3):501-4. PubMed ID: 19773263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron and hepcidin: a story of recycling and balance.
    Camaschella C
    Hematology Am Soc Hematol Educ Program; 2013; 2013():1-8. PubMed ID: 24319154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublethal exposure of organophosphate pesticide chlorpyrifos alters cellular iron metabolism in hepatocytes and macrophages.
    Sun L; Zhang S; Guo W; He W; Qian Y; Qu G; Ji H; Rong H; Liu S
    Int J Mol Med; 2014 Nov; 34(5):1395-400. PubMed ID: 25176568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies of duodenal and macrophage ferroportin proteins.
    Canonne-Hergaux F; Donovan A; Delaby C; Wang HJ; Gros P
    Am J Physiol Gastrointest Liver Physiol; 2006 Jan; 290(1):G156-63. PubMed ID: 16081760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepcidin-ferroportin axis in health and disease.
    Ginzburg YZ
    Vitam Horm; 2019; 110():17-45. PubMed ID: 30798811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional properties of human ferroportin, a cellular iron exporter reactive also with cobalt and zinc.
    Mitchell CJ; Shawki A; Ganz T; Nemeth E; Mackenzie B
    Am J Physiol Cell Physiol; 2014 Mar; 306(5):C450-9. PubMed ID: 24304836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia.
    Manolova V; Nyffenegger N; Flace A; Altermatt P; Varol A; Doucerain C; Sundstrom H; Dürrenberger F
    J Clin Invest; 2019 Dec; 130(1):491-506. PubMed ID: 31638596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The iron-regulatory hormone hepcidin: a possible therapeutic target?
    Rochette L; Gudjoncik A; Guenancia C; Zeller M; Cottin Y; Vergely C
    Pharmacol Ther; 2015 Feb; 146():35-52. PubMed ID: 25205158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.